Theralink Technologies Statistics
Total Valuation
Theralink Technologies has a market cap or net worth of 6,151. The enterprise value is 23.74 million.
| Market Cap | 6,151 |
| Enterprise Value | 23.74M |
Important Dates
The last earnings date was Friday, January 3, 2025.
| Earnings Date | Jan 3, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Theralink Technologies has 6.15 billion shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 6.15B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.00% |
| Owned by Institutions (%) | n/a |
| Float | 1.07B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.01 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.76 |
| EV / Sales | 37.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.64 |
Financial Position
The company has a current ratio of 0.00
| Current Ratio | 0.00 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.64 |
| Interest Coverage | -0.39 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -191.54% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | 39,716 |
| Profits Per Employee | -843,612 |
| Employee Count | 16 |
| Asset Turnover | 0.25 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 20.37 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 34.06 |
| Average Volume (20 Days) | 1,079,828 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.03 |
Income Statement
In the last 12 months, Theralink Technologies had revenue of 635,450 and -13.50 million in losses. Loss per share was -0.00.
| Revenue | 635,450 |
| Gross Profit | 390,204 |
| Operating Income | -7.71M |
| Pretax Income | -13.50M |
| Net Income | -13.50M |
| EBITDA | -7.51M |
| EBIT | -7.71M |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 24,270 in cash and 23.76 million in debt, giving a net cash position of -23.73 million or -0.00 per share.
| Cash & Cash Equivalents | 24,270 |
| Total Debt | 23.76M |
| Net Cash | -23.73M |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -57.12M |
| Book Value Per Share | -0.01 |
| Working Capital | -57.53M |
Cash Flow
In the last 12 months, operating cash flow was -4.96 million and capital expenditures -155,400, giving a free cash flow of -5.12 million.
| Operating Cash Flow | -4.96M |
| Capital Expenditures | -155,400 |
| Free Cash Flow | -5.12M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 61.41% |
| Operating Margin | -1,213.62% |
| Pretax Margin | -2,124.13% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Theralink Technologies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.01% |
| Shareholder Yield | -2.01% |
| Earnings Yield | -219,440.68% |
| FCF Yield | -83,184.83% |
Stock Splits
The last stock split was on September 12, 2019. It was a reverse split with a ratio of 0.0013333.
| Last Split Date | Sep 12, 2019 |
| Split Type | Reverse |
| Split Ratio | 0.0013333 |
Scores
Theralink Technologies has an Altman Z-Score of -140.97. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -140.97 |
| Piotroski F-Score | n/a |